2018 - 2026
Need a report that reflects how COVID-19 has impacted this market and its growth?
The Japan Veterinary Healthcare Market was valued at USD 1881.31 million in 2020, and it is expected to reach USD 3014.14 million by 2026, registering a CAGR of 8.57% during 2021-2026. The outbreak of COVID-19 has impacted all industries including Japan's veterinary healthcare market. Pet parents are advised to keep a safe distance from their pets in order to reduce the risk of contamination and maintain hygiene. There has been difficulty in moving animal products such as milk, eggs, meat to markets. The restriction were been implemented on the seasonal border crossing with ruminants.
Pet adoptions increased during this pandemic situation. A 2020 survey conducted by the Japan Pet Food Association found a 15 percent increase in dog and cat ownership compared with the previous year 2019. There were an estimated 8.49 million dogs and 9.64 million cats being kept as pets in Japan as of October 2020. Several animal shelters, non-profit rescue organizations, private breeders, and pet stores observed increased consumer demand. Thus, the rising adoption of pets may drive the growth of the Japanese veterinary healthcare market in the longer term.
The risk from zoonotic diseases is fueling the market for Japan veterinary healthcare. Inter-Governmental Organizations and food production are making reforms to ensure health by the process of surveillance and vaccination, investing in R&D, and transfer with respect to vet health. Additionally, advanced technology leading to innovations in animal healthcare, increase in ownership of pet animals and increasing awareness about the health of animals consumed as food are also the factors responsible for the growth of Japan veterinary healthcare market.
Also, recent outbreaks such as pathogenic avian influenza (HPAI) is affecting quality life of poultry animals. For instance, in 2020, Japan detected a new outbreak of bird flu “avian influenza”. As per the news article published in 2020 “Bird flu spreads to 10th Japanese prefecture”, reported that around 5.5 million poultry had been slaughtered to contain virus. Also, Japan culled around 77,000 chickens over new bird flu outbreak in Tochigi. This unprecedented increase in such infectious disease prevalence has triggered companies to produce advanced vaccines and pharmaceuticals.
However, increasing costs of animal testing and veterinary services, lack of infrastructure and funding and use of counterfeit medicines are restraining the growth of Japan veterinary healthcare market.
Scope of the Report
As per the scope of this report, the Japan veterinary healthcare market is growing, comprising therapeutic products and solutions for companion and farm animals. Companion animals can be tamed or adopted for companionship or as house/office guards, and farm animals are raised for meat and milk-related products. Companion animals include canine, feline, and equine. Farm animals are bovine, poultry, and porcine. The Japan veterinary healthcare market is segmented by Product (therapeutics and diagnostics) and animal type (dogs and cats, horses, ruminants, swine, poultry, and other animals). The therapeutics segment is further subdivided into vaccines, parasiticides, anti-infectives, medical feed additives, and other therapeutics. The diagnostics segment is further divided into immunodiagnostic tests, molecular diagnostics, diagnostic imaging, clinical chemistry, and other diagnostics. The report offers the value (in USD million) for the above segments.
|By Animal Type|
|Dogs and Cats|
Key Market Trends
Vaccine by Theapeitics Segment holds the major share in Japan Veterinary Healthcare Market
Vaccines are comprised of viruses, bacteria, or other disease-causing organisms that have been killed or altered so that they cannot cause any disease, thus, boosting immunity. New advanced vaccines have been manufactured containing genetically engineered components derived from those disease agents.
The vaccines segment is expected to be driven by innovations in vaccines, growing awareness of animal health, increasing investments by government bodies and associations, increasing demand for animal protein, including milk, meat, eggs, and fish, and rising healthcare expenditure for companion animals.
A strong foothold of key market players offering a wide range of products in the arena of veterinary vaccine is likely to fuel the segmental growth over upcoming years. For instance, Kyoritsu seiyaku Corporation is offering vaccines namely Canivac KC-3 for Prevention of canine adenovirus (type 2) infection, canine parainfluenza & canine Bordetella infection and Felivac 3 for the prevention of feline viral rhinotracheitis, feline calicivirus infection, and feline panleukopenia. Thus, the easy availability of such product will likely boost the growth of this segment over the forecast period.
Additionally, market players are focusing on the launch of new vaccines across Japan to enhance their market presence. For instance, in 2019, German market player Verovaccines GmbH signed the first cooperation agreement with a Japanese pharmaceutical partner for the joint development of an animal vaccine to develop and commercialize novel, cost-effective vaccines with high safety and efficacy for animal health.
In 2017, Biogal Galed Labs had announced the launch of Canine VacciCheck in Japan. Canine VacciCheck had been approved by The Ministry of Agriculture, Forestry and Fisheries (MAFF) in Japan. VacciCheck is a titre test that measures the antibody levels in the blood. The test helps reduce vaccination failure, prevents over-vaccination consequences and helps owners and vets to make informed vaccination decisions. Thus, due to the factors mentioned above, the growth of the vaccines segment is estimated to grow steadily during the forecast period.
To understand key trends, Download Sample Report
The market for Japan Veterinary Healthcare is majorly dominated by the few players. However, there are few companies that are penetrating the market currently and are expected to hold a substantial share in the market. Major players of the market are Zoetis Inc., Virbac, DS Pharma Animal Health Co., Carus Animal Health Ltd, Nisseiken Co., Ltd., Sumitomo Corporation, NIHON NOHYAKU CO., LTD., NIPPON ZENYAKU KOGYO CO., LTD. amongst others
- In March 2021, Virbac obtained worldwide rights to two companion animal products (Itrafungol and Clomicalm) with full-year sales of around Eur 11 million from Elanco.
- In February 2021, Carus Animal Health and SpheriTech sign license agreement to develop veterinary applications for SpheriSome technology.
Table of Contents
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.1.1 Advanced Technology Leading to Innovations in Animal Healthcare
4.1.2 Increasing Productivity at the Risk of Emerging Zoonosis
4.2 Market Restraints
4.2.1 Increasing Cost of Animal Testing and Veterinary Services
4.2.2 Use of Counterfeit Medicines
4.3 Porter's Five Force Analysis
4.3.1 Threat of New Entrants
4.3.2 Bargaining Power of Buyers/Consumers
4.3.3 Bargaining Power of Suppliers
4.3.4 Threat of Substitute Products
4.3.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Product
5.1.1 By Therapeutics
184.108.40.206 Medical Feed Additives
220.127.116.11 Other Therapeutics
5.1.2 By Diagnostics
18.104.22.168 Immunodiagnostic Tests
22.214.171.124 Molecular Diagnostics
126.96.36.199 Diagnostic Imaging
188.8.131.52 Clinical Chemistry
184.108.40.206 Other Diagnostics
5.2 By Animal Type
5.2.1 Dogs and Cats
5.2.6 Other Animals
6. COMPETITIVE LANDSCAPE
*List Not Exhaustive
6.1 Company Profiles
6.1.1 Elanco Animal Health Incorporated
6.1.2 Boehringer Ingelheim GmbH
6.1.3 Kyoritsu Seiyaku Corporation (Carus Animal Health)
6.1.4 FUJIFILM Holdings Corporation
6.1.5 Merck & Co., Inc.
6.1.6 NIHON NOHYAKU CO.,LTD.
6.1.7 NIPPON ZENYAKU KOGYO CO., LTD.
6.1.8 Nisseiken Co., Ltd.
6.1.9 Sumitomo Dainippon Pharma Co., Ltd
6.1.11 Zoetis Inc.
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
You can also purchase parts of this report. Do you want to check out a section wise price list?
Frequently Asked Questions
What is the study period of this market?
The Japan Veterinary Healthcare Market market is studied from 2018 - 2026.
What is the growth rate of Japan Veterinary Healthcare Market?
The Japan Veterinary Healthcare Market is growing at a CAGR of 8.57% over the next 5 years.
What is Japan Veterinary Healthcare Market size in 2018?
The Japan Veterinary Healthcare Market is valued at 1881 Million USD in 2018.
What is Japan Veterinary Healthcare Market size in 2026?
The Japan Veterinary Healthcare Market is valued at 3014 Million USD in 2026.
Who are the key players in Japan Veterinary Healthcare Market?
- DS Pharma Animal Health Co.
- Nisseiken Co., Ltd.
- NIPPON ZENYAKU KOGYO CO., LTD.
- Zoetis Inc.
- Elanco Animal Health Incorporated
Are the major companies operating in Japan Veterinary Healthcare Market.